Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled N-acetylcysteine for pulmonary complications after liver transplantation
ChiCTR-TRC-14005169Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Jan 1990
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of acetylcysteine in hepatic disease (3 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Incidence of pulmonary complications, Duration of ICU stay and 1 more. Started Jan 1990; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
hepatic disease
Beyond the preview
Go deeper on ChiCTR-TRC-14005169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14005169.